CANG vs HIVE
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 09, 2026
CANG
HIVE
Investment Advisor Scores
HIVE
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CANG | HIVE | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 16 | 62.8931 | CANG |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -33.2% | 130.5% | HIVE |
| Earnings Growth | 137.3% | -99.9% | CANG |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 35.6/100 | 61.6/100 | HIVE |
| Profit Margin | -131.7% | -49.9% | HIVE |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | SELL | HOLD | HIVE |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CANG
MarkupPrice above SMA50, rising 50-day trend (74.6% over 20 days), RSI 71
HIVE
MarkdownPrice below a falling SMA50 (slope -1.8%), weak momentum, RSI 43
Fundamentals Snapshot
| Metric | CANG | HIVE |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 2.4 | -5.6 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.3% | 1.3% |
| Gross Margin | 0.0% | 0.4% |
| Operating Margin | -0.3% | -0.8% |
| EPS | -21.76 | -0.64 |
| Dividend Yield | — | — |